Metraipolis › archive › dc_27da20eb001e
Treatment completion rates and adverse effects of three months of once-weekly isoniazid plus rifapentine for latent tuberculosis infection — Europe PMC PMID:41191713
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41191713
- DOI
- 10.36416/1806-3756/e20250234
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T00:50:58.391Z
- SHA-256 of the archived text
a4561cf273da9f553e8a8d6e314e210494624101417db07694241d3e03feb087- Stable URL of this page
https://metraipolis.com/documento/dc_27da20eb001e
How to cite
Treatment completion rates and adverse effects of three months of once-weekly isoniazid plus rifapentine for latent tuberculosis infection — Europe PMC PMID:41191713 — Europe PMC (en), https://europepmc.org/article/MED/41191713 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_27da20eb001e (Metraipolis archive dc_27da20eb001e, sha256 a4561cf273da9f553e8a8d6e314e210494624101417db07694241d3e03feb087)
BibTeX
@misc{dc27da20eb001e,
title = {Treatment completion rates and adverse effects of three months of once-weekly isoniazid plus rifapentine for latent tuberculosis infection — Europe PMC PMID:41191713},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41191713},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_27da20eb001e; sha256 a4561cf273da9f553e8a8d6e314e210494624101417db07694241d3e03feb087},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41191713. Agents can read the archived copy with the MCP tool read_document.